Can valproic acid (Depakote), eszopiclone (Lunesta), lamotrigine (Lamictal), or pregabalin (Lyrica) cause tremor and altered mental status?

Yes, all four of these medications can cause tremor and altered mental status

Depakote (valproic acid) is the most concerning culprit and must be considered first when evaluating tremor and altered mental status in a patient on this regimen. Valproic acid can cause both tremor (including resting tremor that mimics Parkinson's disease) and hyperammonemic encephalopathy leading to altered mental status 1, 2. Lyrica (pregabalin) commonly causes tremor, confusion, and "thinking abnormal" (concentration/attention difficulties) 3. Lunesta (eszopiclone) causes cognitive and behavioral changes including confusion and next-morning impairment 4. Lamotrigine can cause tremor, particularly when combined with valproic acid 5.

Depakote (Valproic Acid) - Primary Suspect

Valproic acid causes tremor in approximately 11% of patients and can present as:

• Postural/kinetic tremor (most common)
• Resting tremor that mimics Parkinson's disease, even unilaterally 1, 6
• Disabling tremor requiring drug discontinuation 5

For altered mental status, valproic acid causes hyperammonemic encephalopathy 2:

• Can occur even with therapeutic drug levels
• Presents with progressive obtundation, confusion, and potentially seizures
• Risk increases with polypharmacy (especially other anticonvulsants)
• Resolves with drug discontinuation

The combination of valproic acid with lamotrigine specifically increases tremor risk 5.

Lyrica (Pregabalin) - Second Most Likely

Pregabalin causes tremor in 1-2% of patients in a dose-dependent manner 3. The FDA label explicitly lists:

• Tremor as a documented adverse effect
• Confusion (1-3% incidence)
• "Thinking abnormal" - primarily concentration/attention difficulties (1-3% incidence)
• Ataxia, incoordination, amnesia - all contributing to altered mental status

These effects are dose-related and occur more frequently at 600 mg/day dosing 3.

Lunesta (Eszopiclone) - Cognitive Effects

Eszopiclone causes cognitive and behavioral changes including 4:

• Next-morning impairment affecting driving and cognition
• Confusion and disorientation (5-fold increase in older adults)
• Memory loss
• Residual morning sedation (4-fold increase)

The FDA warns specifically about cognitive impairment that persists into waking hours.

Lamotrigine (Lamictal) - Contributory Role

Lamotrigine alone rarely causes tremor, but when combined with valproic acid, disabling tremor can develop 5. The 2024 guideline shows lamotrigine does not significantly impair arousal or cognitive function when used as monotherapy 7.

Clinical Approach

Check the following in order:

1. Obtain valproic acid level and ammonia level immediately - hyperammonemic encephalopathy is the most dangerous cause
2. Review total daily doses - pregabalin effects are dose-dependent; doses >300 mg/day increase risk
3. Assess timing - eszopiclone effects may be worse in morning; valproic acid tremor can develop after years of use 1
4. Consider drug interactions - valproic acid + lamotrigine combination specifically increases tremor risk 5

If hyperammonemia is present: Discontinue valproic acid immediately; symptoms resolve with supportive care 2.

If tremor is the primary concern: Valproic acid is most likely, especially if resting tremor or if patient is also on lamotrigine. Tremor improves dramatically within 3 months of discontinuation 1.

Common pitfall: Assuming unilateral resting tremor must be Parkinson's disease rather than valproic acid-induced tremor - even asymmetric resting tremor can be drug-induced after long-term valproate exposure 1.